• Vinay Chamola, Rasoul Mohammadi, Harish Nair, Adit Goyal, Aarya Patel, Vikas Hassija, Matteo Bassetti, Pratik Narang, Roger Paredes, Jose R Santos, Seyed Jamal Hashemi, Mahnaz Pejman Sani, Kiana Shirani, Neda Alijani, Bahareh Abtahi Naeini, Mohsen Pourazizi, Seyed Hamidreza Abtahi, Farzin Khorvash, Mahdi Khanjari, and Kazem Ahmadikia.
• Medsupervision Pvt. Ltd., Faridabad, Haryana, India.
• J Res Med Sci. 2022 Jan 1; 27: 57.

AbstractAt a time when the COVID-19's second wave is still picking up in countries like India, a number of reports describe the potential association with a rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.Copyright: © 2022 Journal of Research in Medical Sciences.

6 keywords...

hide…